Glaucoma and Glutamine: Is There a Real Link Through Glutamate, Retinal Metabolism, and Neurodege...

This audio article is from VisualFieldTest.com (https://visualfieldtest.com) . Read the full article here: https://visualfieldtest.com/en/glauco... Test your visual field online: https://visualfieldtest.com Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/su... Excerpt: Executive Summary Glutamine is a common amino acid in the body, but current evidence does not show that glutamine itself causes or treats glaucoma. Instead, glutamine is part of the normal glutamate–glutamine cycle in the nervous system, including the retina (). In glaucoma (a disease where retinal ganglion cells and the optic nerve degenerate), researchers have wondered whether excitotoxic damage from too much glutamate may play a role. Since glutamine is the main precursor for glutamate, it is studied as an indirect marker of this process. Some experimental studies (mostly in animals or lab models) show changes in glutamine handling by retinal glial cells when pressure or blood flow is disturbed. A few small human studies found glaucoma patients had slightly higher glutamine in the eye’s fluids (), while others found no difference () (). Overall the human data are limited and inconsistent. Glutamine supplements have not been shown to help glaucoma, and no clinical trial has tested this. There is also no evidence that taking or avoiding glutamine changes eye pressure or disease. In practical terms, the main proven treatment for glaucoma remains lowering eye pressure (with drops, laser, or surgery), not dietary changes. What is Glutamine? Glutamine (Gln) is one of the body’s most abundant free amino acids. It serves many roles: a building block for proteins, a fuel for immune and gut cells, and a carrier of nitrogen between tissues (). Under stress or illness, cells use glutamine quickly and it can become “conditionally essential” (meaning we may need more from food or supplements) (). Glutamate (Glu) is a closely related amino acid that acts as a major excitatory neurotransmitter in the brain and retina. In contrast, glutamine itself is not an excitatory neurotransmitter. Instead, it is a “converter” or storage form. Neurons use glutamine mostly to re-synthesize glutamate. High extracellular glutamate can be toxic to neurons (a process called excitotoxicity), but glutamine is not toxic and does not directly activate glutamate receptors (). The glutamate–glutamine cycle: In the retina (and brain), neurons and glial cells recycle glutamate and glutamine in a tight loop (). For example: A neuron (such as a retinal ganglion cell) releases glutamate at its synapse. Nearby Müller glial cells (the main support cells in the retina) quickly take up this glutamate and convert it into glutamine (). The Müller cell then releases glutamine back to neurons. Neurons take up glutamine and convert it back into glutamate for future signaling. In effect, glutamine is a “safe” way to mop up excess glutamate. It keeps the fast-acting glutamate neurotransmitter within neurons and prevents glutamate from lingering too long outside cells, which could be harmful (). The cycle is illustrated conceptually below: Neuron releases glutamate → Glial cell converts glutamate → glutamine → Glial cell sends glutamine back → Neuron converts glutamine back to glutamate. () This recycling ensures that neurotransmitter levels remain balanced. Importantly, disturbances in this cycle (for example if glial cells fail to clear glutamate) can allow glutamate buildup and potentially cause excitotoxic damage to neurons. Why Could Glutamine Matter in Glaucoma? Glaucoma basics: Glaucoma is a group of eye diseases leading to optic nerve damage and vision loss, usually by death of retinal ganglion cells (RGCs). The most common form is primary open-angle glaucoma (POAG), often associated with elevated intraocular pressure (IOP). Another form is normal-tension glaucoma, where nerve damage occurs at normal pressures. Regardless of pressure, glaucoma involves progressive RGC loss. The National Eye Institute and others describe glaucoma as an optic neuropathy (nerve disease) that leads to peripheral vision loss and eventual blindness if untreated () (). Excitotoxicity hypothesis: Because glutamate is known to kill retinal neurons in lab studies (for example, injecting glutamate into the eye causes RGC death), scientists have long hypothesized that elevated glutamate could contribute to glaucoma damage. Some early studies reported higher vitreous (eye fluid) glutamate in glaucomatous eyes, suggesting an “excitotoxic” mechanism () (). In one review, it was noted that glaucoma patients had about 27 μM glutamate in vitreous vs 11 μM in controls, enough to harm RGCs (). However, other studies (including Honkanen et al. 2003) found no significant increase in ocular glutamate or glutamine in glaucoma patients () ()...